Skip to main content

Vanderbilt Ingram Cancer Center Archives

Surgery for hereditary breast cancer

Nov. 17, 2022—Similar rates of bilateral mastectomy in women with inherited mutations in high- and moderate-penetrance genes raises concerns about possible overtreatment of some patients, Vanderbilt researchers report.

Read more


Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis

Nov. 16, 2022—Researchers from from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation myocarditis.

Read more


Study finds inherited link to appendix cancer

Nov. 11, 2022—A Vanderbilt study is the first to show inherited risk factors for appendiceal cancer.

Read more


Study reveals pathways for aggressive prostate cancer subtype

Oct. 27, 2022—Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.

Read more


Metabolic signatures of Type 2 diabetes risk

Oct. 24, 2022—Vanderbilt epidemiologists found 32 blood metabolites associated with obesity and showed that adding these to traditional disease prediction models improves accuracy of determining Type 2 diabetes risk.

Read more


Event set to make lung cancer screening more accessible

Oct. 20, 2022—Vanderbilt University Medical Center is making the lung cancer screening more convenient with weekend appointments from 8 a.m. to noon on Saturday, Nov. 12, at Vanderbilt Health One Hundred Oaks

Read more


Osterman appointed chair of mCODE executive committee

Oct. 20, 2022—Vanderbilt's Travis Osterman, DO, MS, has been appointed chair of the executive committee for the Minimal Common Data Elements (mCODE) initiative.

Read more


Vanderbilt Health Pleasant View now open

Sep. 30, 2022—The new Vanderbilt Health Pleasant View outpatient clinic offers greater convenience to primary care and specialized medical services for patients in Cheatham, Montgomery and Robertson counties.

Read more


New Clinician Spotlight: Muhamed Baljević

Sep. 29, 2022—Specializing in myeloma, amyloidosis and other plasma cell disorders, hematologist and medical oncologist Muhamed Baljević, MD, recently joined Vanderbilt University Medical Center.

Read more


Policy, resources crucial for lung cancer screening: study

Sep. 29, 2022—Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.

Read more


Vanderbilt lauded for pancreatic cancer, pancreatitis care

Sep. 29, 2022—Vanderbilt has been recognized as a National Pancreas Foundation Center of Excellence.

Read more


Nerve cells and cancer progression

Sep. 22, 2022—Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more